Clinical Trials Sponsored by SOS Attaque Cérébrale
Total 2 results
-
SOS Attaque CérébraleTerminatedInfarction, Middle Cerebral ArteryFrance
-
SOS Attaque CérébraleNot yet recruitingSleep Apnea Syndromes | Ischemic StrokeFrance
Sponsors and Collaborators
- Victor Montori
- AMTC & Associates
- University Medical Center Goettingen
- San MediTech(Huzhou)Co.,Ltd.
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- Elim Pediatric Pharmaceuticals Inc.
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- Norsk Proteinintolerance, Norway
- Fondren Orthopedic Group L.L.P.
- Societa Italiana di Endoscopia Digestiva
- Caritas Freetown
- CRMBM-CEMEREM
- Donders Institute for Brain, Cognition and Behavior
- ProteoSys AG
- Alberta Children's Hospital, Calgary, Canada
- Cardresearch
- Celtaxsys Aus Pty Limited
- The Fifth Affiliated Hospital of Zunyi Medical College
- Diego Hernan Giunta, MD
- Rui-hua Xu, MD, PhD
- View Full List
Medical Conditions
- Lymphedema of Arm
- Malignant Ascites Due to Epithelial Carcinoma
- Fever, Sweats, and Hot Flashes
- Tube Disorders Eustachian
- Tularaemia
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Postcomatose Unawareness State
- Auditory Hallucination, Verbal
- Non-dystrophic Myotonias
- Orbital Tumor
- Fibromyalgia Syndrome, Primary
- Gynecologic Cancer
- Disturbance of Activity and Attention
- Atrial Fibrillation, Postoperative
- Prostate Cancer Recurrent
- Non-compressible Torso Hemorrhage
- Spermatogenesis Arrest
- Normal Diameter of Optic Nerve
- Stereotactic Radioablation for Ventricular Tachycardia
- Plasmodium Falciparum Malaria (Drug Resistant)
- View Full List
Drug Interventions
- Flibanserin 100 mg dose every evening
- Ruxolitinib
- Insulin
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Lamivudine
- Enzalutamide, Abiraterone
- PF-00868554
- Oxycodone, fentanyl
- Epimedium Prenylflavonoids Extract
- SERETIDE Diskus
- Polyethylene glycol 3350
- Atezolizumab
- Indoximod
- Mupirocin Calcium
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Cytarabine ARA-C
- Topotecan
- Cetrorelix 78 mg + 78 mg
- Methotrexate
- Bortezomib/dexamethasone
- View Full List
CROs by country
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Croatia
- Contract Research Organizations in Ecuador
- Contract Research Organizations in India
- Contract Research Organizations in Latvia
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Poland
- Contract Research Organizations in Portugal
- Contract Research Organizations in South Africa
- Contract Research Organizations in South Korea
- Contract Research Organizations in Suriname
- Contract Research Organizations in United States
- Contract Research Organizations in Venezuela
- CRO list by country